ArticleDiscover oncology2025

A retrospective study of pembrolizumab plus chemotherapy for head and neck cancer patients: influence of response in combination phase on subsequent maintenance phase.

Ken Saijo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.